133 related articles for article (PubMed ID: 35569185)
1. Hirsutine, a novel megakaryopoiesis inducer, promotes thrombopoiesis via MEK/ERK/FOG1/TAL1 signaling.
Kang Y; Lin J; Wang L; Shen X; Li J; Wu A; Yue L; Wei L; Ye Y; Yang J; Wu J
Phytomedicine; 2022 Jul; 102():154150. PubMed ID: 35569185
[TBL] [Abstract][Full Text] [Related]
2. Xanthotoxin, a novel inducer of platelet formation, promotes thrombocytopoiesis via IL-1R1 and MEK/ERK signaling.
Lai J; Li Y; Ran M; Huang Q; Huang F; Zhu L; Wu Y; Zou W; Xie X; Tang Y; Yang F; Wu A; Ge G; Wu J
Biomed Pharmacother; 2023 Jul; 163():114811. PubMed ID: 37156117
[TBL] [Abstract][Full Text] [Related]
3. Novel chemical-structure TPOR agonist, TMEA, promotes megakaryocytes differentiation and thrombopoiesis via mTOR and ERK signalings.
Jiang X; Sun Y; Yang S; Wu Y; Wang L; Zou W; Jiang N; Chen J; Han Y; Huang C; Wu A; Zhang C; Wu J
Phytomedicine; 2023 Feb; 110():154637. PubMed ID: 36610353
[TBL] [Abstract][Full Text] [Related]
4. A Novel Antithrombocytopenia Agent,
Chen W; Zhu L; Wang L; Zeng J; Wen M; Xu X; Zou L; Huang F; Huang Q; Qin D; Mei Q; Yang J; Wang Q; Wu J
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430539
[TBL] [Abstract][Full Text] [Related]
5.
Yang X; Wang L; Zeng J; Wu A; Qin M; Wen M; Zhang T; Chen W; Mei Q; Qin D; Yang J; Jiang Y; Wu J
Pharmaceuticals (Basel); 2022 Sep; 15(10):. PubMed ID: 36297316
[TBL] [Abstract][Full Text] [Related]
6. OP9 bone marrow stroma cells differentiate into megakaryocytes and platelets.
Matsubara Y; Ono Y; Suzuki H; Arai F; Suda T; Murata M; Ikeda Y
PLoS One; 2013; 8(3):e58123. PubMed ID: 23469264
[TBL] [Abstract][Full Text] [Related]
7. Thrombopoietic effects of CCAAT/enhancer-binding protein β on the early-stage differentiation of megakaryocytes.
Song H; Liu J; Tian X; Liu D; Li J; Zhao X; Mei Z; Yan C; Han Y
Arch Biochem Biophys; 2021 May; 703():108846. PubMed ID: 33744198
[TBL] [Abstract][Full Text] [Related]
8. Panax notoginseng saponins induced up-regulation, phosphorylation and binding activity of MEK, ERK, AKT, PI-3K protein kinases and GATA transcription factors in hematopoietic cells.
Sun X; Gao RL; Lin XJ; Xu WH; Chen XH
Chin J Integr Med; 2013 Feb; 19(2):112-8. PubMed ID: 23371459
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a novel megakaryopoiesis enhancer, ingenol, promoting thrombopoiesis through PI3K-Akt signaling independent of thrombopoietin.
Wang L; Zhang T; Liu S; Mo Q; Jiang N; Chen Q; Yang J; Han YW; Chen JP; Huang FH; Li H; Zhou J; Luo JS; Wu JM
Pharmacol Res; 2022 Mar; 177():106096. PubMed ID: 35077844
[TBL] [Abstract][Full Text] [Related]
10. Transcription factor SCL/TAL1 mediates the phosphorylation of MEK/ERK pathway in umbilical cord blood CD34⁺ stem cells during hematopoietic differentiation.
Zhou RQ; Wu JH; Gong YP; Guo Y; Xing HY
Blood Cells Mol Dis; 2014; 53(1-2):39-46. PubMed ID: 24405580
[TBL] [Abstract][Full Text] [Related]
11. PSTPIP2 dysregulation contributes to aberrant terminal differentiation in GATA-1-deficient megakaryocytes by activating LYN.
Liu L; Wen Q; Gong R; Gilles L; Stankiewicz MJ; Li W; Guo M; Li L; Sun X; Li W; Crispino JD; Huang Z
Cell Death Dis; 2014 Jan; 5(1):e988. PubMed ID: 24407241
[TBL] [Abstract][Full Text] [Related]
12. DMAG, a novel countermeasure for the treatment of thrombocytopenia.
Lin J; Zeng J; Liu S; Shen X; Jiang N; Wu YS; Li H; Wang L; Wu JM
Mol Med; 2021 Nov; 27(1):149. PubMed ID: 34837956
[TBL] [Abstract][Full Text] [Related]
13. Sustained activation of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway is required for megakaryocytic differentiation of K562 cells.
Racke FK; Lewandowska K; Goueli S; Goldfarb AN
J Biol Chem; 1997 Sep; 272(37):23366-70. PubMed ID: 9287350
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the Erk2-Elk1 signaling pathway and megakaryocytic differentiation of Bcr-Abl(+) K562 leukemic cells by Gab2.
Dorsey JF; Cunnick JM; Mane SM; Wu J
Blood; 2002 Feb; 99(4):1388-97. PubMed ID: 11830491
[TBL] [Abstract][Full Text] [Related]
15. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
Miranda MB; McGuire TF; Johnson DE
Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
[TBL] [Abstract][Full Text] [Related]
16. Forced FOG1 expression in erythroleukemia cells: Induction of erythroid genes and repression of myelo-lymphoid transcription factor PU.1.
Fujiwara T; Sasaki K; Saito K; Hatta S; Ichikawa S; Kobayashi M; Okitsu Y; Fukuhara N; Onishi Y; Harigae H
Biochem Biophys Res Commun; 2017 Apr; 485(2):380-387. PubMed ID: 28216155
[TBL] [Abstract][Full Text] [Related]
17. Photobiomodulation therapy for thrombocytopenia by upregulating thrombopoietin expression via the ROS-dependent Src/ERK/STAT3 signaling pathway.
Wang Q; Chang H; Shen Q; Li Y; Xing D
J Thromb Haemost; 2021 Aug; 19(8):2029-2043. PubMed ID: 33501731
[TBL] [Abstract][Full Text] [Related]
18. Extracellular signal-regulated kinase/90-KDA ribosomal S6 kinase/nuclear factor-kappa B pathway mediates phorbol 12-myristate 13-acetate-induced megakaryocytic differentiation of K562 cells.
Kim KW; Kim SH; Lee EY; Kim ND; Kang HS; Kim HD; Chung BS; Kang CD
J Biol Chem; 2001 Apr; 276(16):13186-91. PubMed ID: 11278385
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of hypoxia-inducible factor-1α contributes to impaired megakaryopoiesis in immune thrombocytopenia.
Qi J; You T; Pan T; Wang Q; Zhu L; Han Y
Thromb Haemost; 2017 Oct; 117(10):1875-1886. PubMed ID: 28771276
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of GATA-2 inhibits erythroid and promotes megakaryocyte differentiation.
Ikonomi P; Rivera CE; Riordan M; Washington G; Schechter AN; Noguchi CT
Exp Hematol; 2000 Dec; 28(12):1423-31. PubMed ID: 11146164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
